MUC5AC and asthma: One randomized controlled trial reported that MUC5AC expression was downregulated in patients with both CRSwNP and aspirin-resistant asthma after 2 weeks of oral prednisone therapy followed by 12 weeks of intranasal corticosteroids but not in patients with both CRSwNP and aspirin-intolerant asthma [78].